[Clinical care for patients with possible long QT syndrome].
Hayano
Motonobu
M
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial; D017147:Defibrillators, Implantable; D004562:Electrocardiography; D006321:Heart / Q000294:innervation; D006801:Humans; D007473:Ion Channels / Q000235:genetics; D008133:Long QT Syndrome / Q000175:diagnosis / Q000235:genetics / Q000628:therapy*; D009154:Mutation; D011188:Potassium / Q000627:therapeutic use; D026941:Sodium Channel Blockers / Q000627:therapeutic use; D013562:Sympathectomy
D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002121:Calcium Channel Blockers; D007473:Ion Channels; D026941:Sodium Channel Blockers; D011188:Potassium